BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19914139)

  • 1. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay.
    Borgers H; Moens L; Picard C; Jeurissen A; Raes M; Sauer K; Proesmans M; De Boeck K; Casanova JL; Meyts I; Bossuyt X
    Clin Immunol; 2010 Feb; 134(2):198-205. PubMed ID: 19914139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly subjects do not show impaired pneumococcal capsular polysaccharide serotype-specific antibody responses as assessed by a multiplexed bead assay.
    Borgers H; Jeurissen A; Flamaing J; Peetermans WE; Moens L; Verhaegen J; Bossuyt X
    Clin Immunol; 2010 Jun; 135(3):501-2. PubMed ID: 20207588
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
    Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
    Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
    Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
    Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease.
    Mahmoodi M; Aghamohammadi A; Rezaei N; Lessan-Pezeshki M; Pourmand G; Mohagheghi MA; Abdollahzade S; Mousavi-Jarrahi A
    Eur Cytokine Netw; 2009 Jun; 20(2):69-74. PubMed ID: 19541592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
    Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine.
    Borgers H; Meyts I; De Boeck K; Raes M; Sauer K; Proesmans M; Moens L; Jeurissen A; Flamaing J; Peetermans WE; Verhaegen J; Bossuyt X
    Clin Immunol; 2012 Nov; 145(2):136-8. PubMed ID: 23026475
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection.
    Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA
    Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-immunization pneumococcal antibody titers and IgG subclasses.
    Sorensen RU; Hidalgo H; Moore C; Leiva LE
    Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
    Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure.
    O'Brien KL; Moïsi J; Romero-Steiner S; Holder P; Carlone GM; Reid R; Santosham M
    Vaccine; 2009 Mar; 27(12):1863-8. PubMed ID: 19171175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.